CMS-View provides a means for the playback and/or review of medical images or imaging sequences by physicians, scientists or other medical personnel. These medical images may originate from different imaging modalities (x-ray, MRI, ultrasound, nuclear, etc.) and are inpul to the CMS-VIEW system via industry standard formats (DICOM) or by creating a digital equivalent of a video-format (via frame-grabber). Standard image review tools are provided, including zoom, brightness and contrast controls.

The review of medical images is suitable for use by physicians and scientists in the following applications:

Scientific and research studies, selecting and assessing medical images that are of interest,
Review and analysis of patient medical images, providing physicians and administrators with convenient access and review features/capabilities.

Device Description

CMS-View is a professional state-of-the-art DICOM Review Station, designed for use with Microsoft Windows operating systems (preferably, Windows NT). CMS-View facilitates the import and visualization of medical images from a range of different image sources (DICOM-CD, network, VCR, etc.) for use by trained medical personnel (technologists, radiologists, other physicians, etc.). CMS-View may be used either independently or in conjunction with other software products from MEDIS.

AI/ML Overview

I am sorry, but based on the provided document, I cannot extract the detailed information requested regarding the acceptance criteria, study design, and performance metrics.

The document is a 510(k) summary for the "CMS - View" device, which is described as a DICOM Review Station for medical image visualization. It outlines the device's intended use and claims substantial equivalence to a predicate device (RadWorks Medical Imaging Software).

However, the provided text does not contain any information about:

Specific acceptance criteria or reported device performance metrics. The document states that "Potential hazards are controlled by a risk management plan for the software development process (see Appendix C), including hazard analysis, verification and validation tests and evaluations by hospitals," but it does not detail the results or criteria used in these tests.
Sample size used for the test set or data provenance.
Number or qualifications of experts used to establish ground truth.
Adjudication method for the test set.
Multi-reader multi-case (MRMC) comparative effectiveness study.
Standalone (algorithm only) performance study.
Type of ground truth used.
Sample size for the training set.
How ground truth for the training set was established.

The document primarily focuses on establishing substantial equivalence based on technological characteristics and intended use, rather than presenting a performance study with detailed clinical or technical endpoints. It confirms the FDA's clearance of the device based on this substantial equivalence claim.

Summary

{0}------------------------------------------------

K993761

MEDIS medical imaging systems, inc.

DEC 2 8 1999

CMS - View 510(k) Premarket Notification

510(k) SUMMARY OF SAFETY AND EFFECTIVENESS 12 Submission in accordance with the requirements of 21 CFR Part 807.87(h)

Submitter	: MEDIS medical imaging systems, Inc.
Address	: 109 Danbury RoadRidgefield, CT 06877, USA
Telephone	: 203.438.5588
Fax	: 203.438.5393
Contact Person	: Douglas Orr, President
Prepared	: July 30, 1999
2) Device Name	: Cardiovascular Measurement System - View
Common Name	: CMS - View
Device Class. Name	: System, Image Processing;
Regulation Number	: 21 CFR 892.2050 (90 LLZ; Class II)
3) Predicate Device(s)	: RadWorks Medical Imaging Software510(k) Number: K982862 and K962699

Description of the device:

5) Intended use:

CMS-View can be used in the traditional medical image review applications, including cardiac cathetherization rooms, physician offices and other locations apart from the medical clinic or provider location. There are extensive image review controls that are useful to control the viewing process to the preference of the clinical user, supporting visual inspections for further use by a trained medical person.

6) Substantial equivalence Information:

MEDIS believes the CMS-View software is substantially equivalent to the predicate device RadWorks Medical Imaging Software (K982862 / K962699) as both products employ the same technological characteristics and intended use.

Conclusion respecting safety and effectiveness:

It is the opinion of MEDIS medical imaging systems that CMS-View is safe. Potential hazards are controlled by a risk management plan for the software development process (see Appendix C), including hazard analysis, verification and validation tests and evaluations by hospitals. In our opinion the level of concern for the stand alone software to view images is minor and that the use of CMS-View software does not change the intended use of the angiographic imaging systems in practice.

203-438-5588 fax 203-438-5393

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the text "Public Health Service" in bold, black font. The text is horizontally oriented and appears to be a title or heading. The words are stacked on a single line.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Image /page/1/Picture/3 description: The image shows a partial view of a logo or emblem, likely from a government or organizational context. The visible portion features a stylized design of what appears to be an eagle or similar bird of prey, represented by three bold, curved lines suggesting wings or feathers. The word "DEPARTMENT" is partially visible on the left side of the image, indicating that the logo belongs to a department or agency.

DEC 2 8 1999

Douglas F. Orr President Medis Medical Imaging Systems, Inc. 109 Danbury Road Ridgefield, Connecticut 06877

RE:

K993761 CMS - View Dated: July 30, 1999 Received: November 8, 1999 Regulatory Class: II 21 CFR 892.2050/Procode: 90 LLZ

Dear Mr. Orr:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that har abeen redassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Recister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

CART Daniel C. Stultz, M.D.

CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Nov-22-99 @4:19P .... ... ...

203+438+5393

Page 2 - 2 of ___________________________________________________________________________________________________________________________________________________________________________

510(k) Number (if known):

Device Name:

Indications For Use:

510(k) Number: K993761 Device Name: Cardiovascular Measurement system - VIEW (CMS-VIEW)

Indications for Use:

The review of medical images is suitable for use by physicians and scientists in the following applications:

Scientific and research studies, selecting and assessing medical images that are of interest,
Review and analysis of patient medical images, providing physicians and administrators with convenient access and review features/capabilities.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Reproductive, Abdominal, ENT, and Radiological Devices
510(k) Number	K993761

Prescription Use (Per 21 CFR 801.109)	OR	Over-The-Counter Use (Optional Format 1-2-96)
---------------------------------------	----	-----------------------------------------------

Regulation Number and Section

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).